901/1664US=188 / Mono/Enfermagem
Menezes MP. Complicações da mastectomia em pacientes com câncer de mama: uma revisão de literatura. São Paulo, 2012. 61 p. -[Monografia de Conclusão do Curso de Pós Graduação Lato Sensu Enfermagem Oncológica Fundação Antonio Prudente].

NEOPLASIAS DA MAMA; CIRURGIA; MASTECTOMIA; COMPLICACOES POS-OPERATORIAS

902/1664CD/Clipping / US=5 CD/TV
Clipping maio a julho de 2005. Várias entrevistas e reportagens. São Paulo: Comunique, 2005. CD.

CANCER. SOLIDARIEDADE; MORTE; CANCER DE MAMA; CANCER. HEREDITARIEDADE; CANCER DE PROSTATA; CANCER. HABITOS SAUDAVEIS; CANCER DE COLO UTERO. HPV

903/1664CD/Clipping / US=6 CD/TV
Clipping maio e julho de 2005. Várias entrevistas e reportagens. São Paulo: Comunique, 2005. CD.

CANCER. SOLIDARIEDADE; CANCER DE MAMA

904/1664CD/Clipping / US=8 CD/TV
Clipping outubro de 2005. Várias entrevistas e reportagens. São Paulo: Comunique, 2005. CD.

VOLUNTARIADO; VACINA CONTRA HPV; PODER FEMININO. MULHER. TRABALHO; CANCER DE MAMA

905/1664US=12 / CD/Congressos
Simpósio Satélite: Phamacia. I Simpósio Internacional de Oncologia da Mulher: hormônioterapia no câncer de mama metastático. Rio de Janeiro: Pharmacia Oncologia, 2000. CD.

CONGRESSO; TRABALHOS EM EVENTOS

906/1664US=85 / Biol/Mol
Kim MS, Kwon JY, Kang NJ, Lee KW, Lee HJ. Phloretin induces apoptosis in H-Ras MCF10A human breast tumor cells through the activation of p53 via JNK and p38 mitogen-activated protein kinase signaling. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 479-83. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

APOPTOSE; CANCER DE MAMA; JNK; P38 MAPK; FLORETINA

907/1664Câncer
Vieira MA, Tsunoda AT, Silva MC, Andrade CEMC, Fregnani JHTG. Type I and type II endometrial adenocarcinomas: comparative study of ultrasonographic parameters. Applied Cancer Research, São Paulo: Tecmedd, v.30, n.4, p. 345-7, 2010. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR201030p.345-7.pdf

CANCER DE MAMA; QUALIDADE DE VIDA; QUESTIONARIOS; VALIDACAO; REVALIDACAO

908/1664US=96 / Biol/Mol
Nagasaki S, Miki Y, Akahira JI, Suzuki T, Sasano H. 17ß-hydroxysteroid dehydrogenases in human breast cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 25-32. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

17ß-HIDROXIESTEROIDE DESIDROGENASES; 17ß-HSD; ESTROGENIO; CANCER DE MAMA; INTRACRINOLOGY; DEHYDROEPIANDROTERONE; DHEA

909/1664US=96 / Biol/Mol
Nagasaki S, Miki Y, Akahira JI, Suzuki T, Sasano H. 17ß-hydroxysteroid dehydrogenases in human breast cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 25-32. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

17ß-HIDROXIESTEROIDE DESIDROGENASES; 17ß-HSD; ESTROGENIO; CANCER DE MAMA; INTRACRINOLOGY; DEHYDROEPIANDROTERONE; DHEA

910/1664US=96 / Biol/Mol
Parl FF, Dawling S, Roodi N, Crooke PS. Estrogen metabolism and breast cancer: a risk model. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 68-75. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; METABOLISMO; CANCER DE MAMA; RISCO; GENOTIPO; MODELO

911/1664US=96 / Biol/Mol
Parl FF, Dawling S, Roodi N, Crooke PS. New developments in intracrinology of human breast cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 76-9. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; CANCER DE MAMA; SULFATASE; SULFOTRANSFERASE; INTRACRINOLOGY

912/1664US=96 / Biol/Mol
Day JM, Purohit A, Tutill HJ, Foster PA, Woo LWL, Poter BVL, Reed MJ. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 80-7. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

SULFATASE ESTEROIDE; INIBIDORES DE SULFATASE; CANCER DE MAMA; CANCER DE PROSTATA; OVARION CANCER; CANCER DE ENDOMETRIO

913/1664US=96 / Biol/Mol
Lazarus P, Blevins-Primeau AS, Zheng Y, Sun D. Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 99-111. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE MAMA; TAMOXIFENO; UDP GLUCURONOSILTRANSFERASE; GLUCURONIDACAO; METABOLISMO; FARMACOGENETICA

914/1664US=96 / Biol/Mol
Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D. Regulation of aromatase expression in breast cancer tissue. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 121-31. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

BRCA-1; ARF; CREB; AROMATASE; CANCER DE MAMA; PROSTAGLANDINA E2; JUNHO QUINASE; P38 QUINASE; RECEPTOR DE ESTROGENIO-&*945;; INIBIDOR DA AROMATASE

915/1664US=96 / Biol/Mol
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 132-40. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; 4-OH-ESTRADIOL; CANCER DE MAMA; GENOTOXICIDADE; EFEITOS

916/1664US=96 / Biol/Mol
Dunn BK, Ryan A. Phase 3 trials of aromatase inhibitors for breast cancer prevention. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 141-61. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

PREVENCAO DO CANCER DE MAMA; INIBIDOR DA AROMATASE; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENIO; TAMOXIFENO; CANCER DE MAMA CONTRALATERAL; ARIMIDEX; TAMOXIFENO SOZINHO OU EM COMBINACAO; SERM; TAM; AI; CLBC; ATAC

917/1664US=96 / Biol/Mol
Macedo LF, Sabnis G, Brodie A. Aromatase inhibitors and breast cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 162-73. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE MAMA; MODELOS XENOGRAFT; LETROZOL; ANASTROZOL; HER2; TRASTUZUMAB

918/1664US=96 / Biol/Mol
Zarcone M, Amodio R, Campisi I, Cusimano R, Dolcemascolo C, Miceli V, Traina A, Macaluso M. Application of a new classification to a breast tumor series from a population-based cancer registry. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 222-6. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

IHC; CANCER DE MAMA; CLASSIFICACAO LUMINAL; BASAL-LIKE; TRATAMENTO ENDOCRINO; CARACTERISTICAS IMUNOHISTOQUIMICAS

919/1664US=96 / Biol/Mol
Amodio R, Zarcone M, Agostara B, Staiti R, Granata OM, Carruba G, Traina A. Endocrine therapy in metastatic breast cancer: data from breast cancer registry of Palermo, 1999-2005. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 227-31. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE MAMA METASTATICO; ANALISE CIRURGICA; SOBREVIDA GLOBAL; OS; TRATAMENTO HORMONAL; RECEPTOR POSITIVO; RECEPTOR NEGATIVO

920/1664US=96 / Biol/Mol
Marotta F, Yadav H, Pathak S, Minelli E, Signorelli P, Lorenzetti A, Marandola P. Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 273-7. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

LINHAS CELULARES DE CANCRO DA MAMA; IN VIVO MODELO DE CANCER DE MAMA; MANDA-KOSO

Primeira | Anterior | Próxima | Última